Summary
Parmax Pharma share holding pattern reports the following shareholding: Parmax Pharma Total Promoters is at 30.80%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 69.20%. This breakdown provides a quick snapshot of ownership distribution for Parmax Pharma share holding pattern in 2026-27.
Parmax Pharma FAQs
As of 05-2026, the promoter shareholding in Parmax Pharma stands at 30.8% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Parmax Pharma is 0% and 0% respectively.
The retail shareholding of the Parmax Pharma is 69.2%.
Changes in shareholding patterns of Parmax Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Parmax Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
